TU‐A‐BRA‐05: Lung Cancer Patient Feasibility Study for Emission Guided Radiation Therapy

S. Mazin, A. Nanduri, J. Yang, Tokihiro Yamamoto, B. Loo, E. Graves

Research output: Contribution to journalArticle

Abstract

Purpose: Emission guided radiation therapy (EGRT) is a new concept that allows for online biological targeting with radioactive tracers. The concept was previously demonstrated in phantom experiments involving free breathing trajectories. This study involves the first patient imaging data to assess feasibility and estimate performance in a more realistic context. Methods: A proposed EGRT geometry involves rotating two PET detector arcs with a linear accelerator and binary multi‐leaf collimator on a CT gantry to deliver beamlets of radiation dynamically along detected PET emission paths. A lung cancer patient underwent PET‐CT as part of radiotherapy planning. PET list‐mode data were retrospectively used as an input to simulate the EGRT system's response and Monte Carlo simulations were used to calculate the dose to the patient. The gross target volume (GTV) was contoured based on the PET‐CT images and the planning volume (PTV) was defined as a 10 mm extension of the GTV in all directions. The EGRT method was compared to uniformly irradiating the same PTV (IMRT), with both methods normalized for the same integral dose to the chest wall. Physiologic motion was ignored during the dose calculations as the tumor exhibited < 2 mm motion. Results: The dose peaks towards the center of the GTV with the EGRT method. However, even in the presence of this inhomogeneity, the EGRT method resulted in 18% relative increase in dose to 95% of the GTV, and 45% increase in dose to 50% of the GTV, compared to the IMRT method. Both methods were normalized for the same integral dose to the chest wall. Conclusions: The feasibility of EGRT has been demonstrated with PET data from a lung cancer patient. Future work will analyze the ability of EGRT to compensate for motion in PET‐CT patient studies which will include breathing traces to estimate ground truth. RefleXion Medical is a company commercializing PET‐guided radiotherapy. SRM and ASN have financial interest in the company.

Original languageEnglish (US)
Pages (from-to)3888-3889
Number of pages2
JournalMedical Physics
Volume39
Issue number6
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Feasibility Studies
Lung Neoplasms
Radiotherapy
Thoracic Wall
Respiration
Radioactive Tracers
Particle Accelerators
Radiation

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

TU‐A‐BRA‐05 : Lung Cancer Patient Feasibility Study for Emission Guided Radiation Therapy. / Mazin, S.; Nanduri, A.; Yang, J.; Yamamoto, Tokihiro; Loo, B.; Graves, E.

In: Medical Physics, Vol. 39, No. 6, 01.01.2012, p. 3888-3889.

Research output: Contribution to journalArticle

Mazin, S. ; Nanduri, A. ; Yang, J. ; Yamamoto, Tokihiro ; Loo, B. ; Graves, E. / TU‐A‐BRA‐05 : Lung Cancer Patient Feasibility Study for Emission Guided Radiation Therapy. In: Medical Physics. 2012 ; Vol. 39, No. 6. pp. 3888-3889.
@article{f45d7fde9ab6426a8611c41426116a53,
title = "TU‐A‐BRA‐05: Lung Cancer Patient Feasibility Study for Emission Guided Radiation Therapy",
abstract = "Purpose: Emission guided radiation therapy (EGRT) is a new concept that allows for online biological targeting with radioactive tracers. The concept was previously demonstrated in phantom experiments involving free breathing trajectories. This study involves the first patient imaging data to assess feasibility and estimate performance in a more realistic context. Methods: A proposed EGRT geometry involves rotating two PET detector arcs with a linear accelerator and binary multi‐leaf collimator on a CT gantry to deliver beamlets of radiation dynamically along detected PET emission paths. A lung cancer patient underwent PET‐CT as part of radiotherapy planning. PET list‐mode data were retrospectively used as an input to simulate the EGRT system's response and Monte Carlo simulations were used to calculate the dose to the patient. The gross target volume (GTV) was contoured based on the PET‐CT images and the planning volume (PTV) was defined as a 10 mm extension of the GTV in all directions. The EGRT method was compared to uniformly irradiating the same PTV (IMRT), with both methods normalized for the same integral dose to the chest wall. Physiologic motion was ignored during the dose calculations as the tumor exhibited < 2 mm motion. Results: The dose peaks towards the center of the GTV with the EGRT method. However, even in the presence of this inhomogeneity, the EGRT method resulted in 18{\%} relative increase in dose to 95{\%} of the GTV, and 45{\%} increase in dose to 50{\%} of the GTV, compared to the IMRT method. Both methods were normalized for the same integral dose to the chest wall. Conclusions: The feasibility of EGRT has been demonstrated with PET data from a lung cancer patient. Future work will analyze the ability of EGRT to compensate for motion in PET‐CT patient studies which will include breathing traces to estimate ground truth. RefleXion Medical is a company commercializing PET‐guided radiotherapy. SRM and ASN have financial interest in the company.",
author = "S. Mazin and A. Nanduri and J. Yang and Tokihiro Yamamoto and B. Loo and E. Graves",
year = "2012",
month = "1",
day = "1",
doi = "10.1118/1.4735873",
language = "English (US)",
volume = "39",
pages = "3888--3889",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - TU‐A‐BRA‐05

T2 - Lung Cancer Patient Feasibility Study for Emission Guided Radiation Therapy

AU - Mazin, S.

AU - Nanduri, A.

AU - Yang, J.

AU - Yamamoto, Tokihiro

AU - Loo, B.

AU - Graves, E.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Purpose: Emission guided radiation therapy (EGRT) is a new concept that allows for online biological targeting with radioactive tracers. The concept was previously demonstrated in phantom experiments involving free breathing trajectories. This study involves the first patient imaging data to assess feasibility and estimate performance in a more realistic context. Methods: A proposed EGRT geometry involves rotating two PET detector arcs with a linear accelerator and binary multi‐leaf collimator on a CT gantry to deliver beamlets of radiation dynamically along detected PET emission paths. A lung cancer patient underwent PET‐CT as part of radiotherapy planning. PET list‐mode data were retrospectively used as an input to simulate the EGRT system's response and Monte Carlo simulations were used to calculate the dose to the patient. The gross target volume (GTV) was contoured based on the PET‐CT images and the planning volume (PTV) was defined as a 10 mm extension of the GTV in all directions. The EGRT method was compared to uniformly irradiating the same PTV (IMRT), with both methods normalized for the same integral dose to the chest wall. Physiologic motion was ignored during the dose calculations as the tumor exhibited < 2 mm motion. Results: The dose peaks towards the center of the GTV with the EGRT method. However, even in the presence of this inhomogeneity, the EGRT method resulted in 18% relative increase in dose to 95% of the GTV, and 45% increase in dose to 50% of the GTV, compared to the IMRT method. Both methods were normalized for the same integral dose to the chest wall. Conclusions: The feasibility of EGRT has been demonstrated with PET data from a lung cancer patient. Future work will analyze the ability of EGRT to compensate for motion in PET‐CT patient studies which will include breathing traces to estimate ground truth. RefleXion Medical is a company commercializing PET‐guided radiotherapy. SRM and ASN have financial interest in the company.

AB - Purpose: Emission guided radiation therapy (EGRT) is a new concept that allows for online biological targeting with radioactive tracers. The concept was previously demonstrated in phantom experiments involving free breathing trajectories. This study involves the first patient imaging data to assess feasibility and estimate performance in a more realistic context. Methods: A proposed EGRT geometry involves rotating two PET detector arcs with a linear accelerator and binary multi‐leaf collimator on a CT gantry to deliver beamlets of radiation dynamically along detected PET emission paths. A lung cancer patient underwent PET‐CT as part of radiotherapy planning. PET list‐mode data were retrospectively used as an input to simulate the EGRT system's response and Monte Carlo simulations were used to calculate the dose to the patient. The gross target volume (GTV) was contoured based on the PET‐CT images and the planning volume (PTV) was defined as a 10 mm extension of the GTV in all directions. The EGRT method was compared to uniformly irradiating the same PTV (IMRT), with both methods normalized for the same integral dose to the chest wall. Physiologic motion was ignored during the dose calculations as the tumor exhibited < 2 mm motion. Results: The dose peaks towards the center of the GTV with the EGRT method. However, even in the presence of this inhomogeneity, the EGRT method resulted in 18% relative increase in dose to 95% of the GTV, and 45% increase in dose to 50% of the GTV, compared to the IMRT method. Both methods were normalized for the same integral dose to the chest wall. Conclusions: The feasibility of EGRT has been demonstrated with PET data from a lung cancer patient. Future work will analyze the ability of EGRT to compensate for motion in PET‐CT patient studies which will include breathing traces to estimate ground truth. RefleXion Medical is a company commercializing PET‐guided radiotherapy. SRM and ASN have financial interest in the company.

UR - http://www.scopus.com/inward/record.url?scp=85024807209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024807209&partnerID=8YFLogxK

U2 - 10.1118/1.4735873

DO - 10.1118/1.4735873

M3 - Article

AN - SCOPUS:85024807209

VL - 39

SP - 3888

EP - 3889

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -